Two Mechanisms One Molecule: Developing a ‘Truly’ Bifunctional Degrader Targeting Rpn13 and CRBN
Truly-4 is the first noncovalent small molecule shown to degrade full-length Rpn13, a target previously approached using covalent or domain-restricted strategies, and establishes a generalizable framework for engineering bifunctional degraders that program the proteasome to execute parallel degradation mechanisms and h...